Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Michael A. Klufas, MD
What's Next in Uveitis Care?
Steven Yeh, MD, FASRS
Seeing the Future of Vitreoretinal Care
Prethy Rao MD, MPH, FACS
Why Staging TED Correctly Matters Even When CAS Is Low
Andrea Lora Kossler, MD, FACS
Kimberly Cockerham, MD
Applying CAS, EUGOGO, VISA: A Micro Case
Prem S. Subramanian, MD, PhD
Understanding IGF-1R Inhibition: Mechanism & Clinical Implications
Designing Efficient Clinic Workflows for TED Therapy Access
Comparing Trial Designs & Outcomes Across IGF-1R Therapies
Overcoming Real-World Barriers to TED Treatment
Beyond IGF-1R: IL-6R Inhibition and Future Sequencing
Recognizing Geographic Atrophy Progression in AMD
Brian P. McDonough, MD, FAAFP
Jaclyn Kovach, MD
Advancing Uveitis Care: Emerging Challenges and Research Opportunities
Managing RVO: Goals of Early Intervention
Michael Javaheri, MD, MSc, FASRS
Choosing the Right Therapy for RVO Patients
Highlights from VBS 2026: From Care Innovations to Clinician Wellness
Akshay Thomas, M.D., M.S., FASRS
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Andrew G. Lee, MD
Valerie Biousse, MD
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.